<p>Globally, there are 1.2&#xa0;million new chronic <i>Hepatitis B Virus</i> (<i>HBV</i>) infections every year. The UAE is a low-endemic region where no previous studies have explored <i>HBV</i> stigma. This study aims to evaluate the UAE’s population <i>HBV</i> knowledge, <i>HBV</i> vaccine attitudes, and stigmatizing attitudes towards the <i>HBV</i> infection. A cross-sectional study was conducted to evaluate knowledge and stigma; the previously-developed and validated stigma scale (<i>Hepatitis B Virus</i> – Stigma Scale, <i>HBV</i>-SS) was used. A total of 601 responses were retained for analysis in both python-3 and R. Chi-squared, Mann-Whitney U and Kruskal-Wallis tests were used for bivariate analyses and ordinary least squares (OLS) regression was used for linear modelling. Confirmatory factor analysis (CFA) was conducted, and goodness-of-fit was evaluated. Overall, 77.5%, (<i>n</i> = 466/601) reported having some knowledge regarding <i>HBV</i>, only 19.3% (<i>n</i> = 90/466) had good knowledge regarding <i>HBV</i>, with most gaps occurring with symptoms, complications, and treatment of the infection. However, 84.03% (<i>n</i> = 505/601) were interested in learning more about the virus. Only 57.6% (<i>n</i> = 346/601) were aware of the existence of the vaccine; however, attitudes to it were overwhelmingly positive. Overall, non-stigmatising attitudes dominated; however, both labelling and separating domains highlighted specific items with highly stigmatising attitudes. CFA showed the <i>HBV</i>-SS model to have acceptable/good goodness-of-fit. OLS identified higher knowledge levels among healthcare workers and those with higher perceived knowledge. Only perceived knowledge was a significant predictor of lower stigma beyond the bivariate level. The UAE population has shown low levels of knowledge but overall non-stigmatising attitudes. It is imperative that campaigns focus on improving general population <i>HBV</i> infection and vaccine knowledge while also solidifying the widespread level of vaccine acceptance and non-stigmatising attitudes.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Hepatitis B knowledge and stigma in the United Arab Emirates

  • Hiba Jawdat Barqawi,
  • Kamel A. Samara,
  • Maryam Mohanad Al Ansari,
  • Almuzaffar Mustafa Al Moukdad,
  • Said Hkmat Obied,
  • Eman Abu-Gharbieh

摘要

Globally, there are 1.2 million new chronic Hepatitis B Virus (HBV) infections every year. The UAE is a low-endemic region where no previous studies have explored HBV stigma. This study aims to evaluate the UAE’s population HBV knowledge, HBV vaccine attitudes, and stigmatizing attitudes towards the HBV infection. A cross-sectional study was conducted to evaluate knowledge and stigma; the previously-developed and validated stigma scale (Hepatitis B Virus – Stigma Scale, HBV-SS) was used. A total of 601 responses were retained for analysis in both python-3 and R. Chi-squared, Mann-Whitney U and Kruskal-Wallis tests were used for bivariate analyses and ordinary least squares (OLS) regression was used for linear modelling. Confirmatory factor analysis (CFA) was conducted, and goodness-of-fit was evaluated. Overall, 77.5%, (n = 466/601) reported having some knowledge regarding HBV, only 19.3% (n = 90/466) had good knowledge regarding HBV, with most gaps occurring with symptoms, complications, and treatment of the infection. However, 84.03% (n = 505/601) were interested in learning more about the virus. Only 57.6% (n = 346/601) were aware of the existence of the vaccine; however, attitudes to it were overwhelmingly positive. Overall, non-stigmatising attitudes dominated; however, both labelling and separating domains highlighted specific items with highly stigmatising attitudes. CFA showed the HBV-SS model to have acceptable/good goodness-of-fit. OLS identified higher knowledge levels among healthcare workers and those with higher perceived knowledge. Only perceived knowledge was a significant predictor of lower stigma beyond the bivariate level. The UAE population has shown low levels of knowledge but overall non-stigmatising attitudes. It is imperative that campaigns focus on improving general population HBV infection and vaccine knowledge while also solidifying the widespread level of vaccine acceptance and non-stigmatising attitudes.